Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)

Overview of attention for article published in Journal of Medical Genetics, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 17 X posts from 14 X users, with an upper bound of 10,719 followers.

RT @ER_Woodward: 🧬 early detection is key to improving outcomes in families with hereditary cancer predisposition. Here we show annual imag…

RT @ER_Woodward: 🧬 early detection is key to improving outcomes in families with hereditary cancer predisposition. Here we show annual imag…

RT @ER_Woodward: 🧬 early detection is key to improving outcomes in families with hereditary cancer predisposition. Here we show annual imag…

RT @ER_Woodward: 🧬 early detection is key to improving outcomes in families with hereditary cancer predisposition. Here we show annual imag…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.